AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany
Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.) ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (" AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s (" Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (" CC Pharma"), have entered into a strategic agreement (the " Co-Promotion Agreement") covering joint marketing of sales for Aphria brand medical cannabis products for the German market. The Co-Promotion Agreement is a collaboration contract between AMP and ...